October 03, 2022
A Delaware federal judge has rebuffed a biotechnology company's bid for a new trial after a jury determined it owed a rival and Massachusetts General Hospital $4.7 million for infringing their genetic testing patents, while agreeing with some of the plaintiffs' requests to boost their award.
August 27, 2021
A Delaware federal jury on Friday found that European genetic testing company Qiagen willfully infringed a pair of patents owned by Massachusetts General Hospital and biotech company ArcherDX, awarding royalties and lost profits totaling about $4.7 million.
August 19, 2021
Ferring Pharmaceuticals will argue next week that Jones Day should be sanctioned for sparking a patent trial that never should have happened. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.